| Antimicrobial Ambiguines from the Cyanobacterium Fischerella sp. Collected in Israel A Raveh, S Carmeli Journal of natural products 70 (2), 196-201, 2007 | 199 | 2007 |
| Discovery of potent broad spectrum antivirals derived from marine actinobacteria A Raveh, PC Delekta, CJ Dobry, W Peng, PJ Schultz, PK Blakely, AW Tai, ... PloS one 8 (12), e82318, 2013 | 123 | 2013 |
| Hapalindole/ambiguine biogenesis is mediated by a Cope rearrangement, C–C bond-forming cascade S Li, AN Lowell, F Yu, A Raveh, SA Newmister, N Bair, JM Schaub, ... Journal of the American Chemical Society 137 (49), 15366-15369, 2015 | 72 | 2015 |
| Purpurin modulates Tau-derived VQIVYK fibrillization and ameliorates Alzheimer’s disease-like symptoms in animal model GK Viswanathan, D Shwartz, Y Losev, E Arad, C Shemesh, E Pichinuk, ... Cellular and Molecular Life Sciences 77, 2795-2813, 2020 | 62 | 2020 |
| Fibril formation and therapeutic targeting of amyloid-like structures in a yeast model of adenine accumulation D Laor, D Sade, S Shaham-Niv, D Zaguri, M Gartner, V Basavalingappa, ... Nature communications 10 (1), 62, 2019 | 57 | 2019 |
| Actinoramide A identified as a potent antimalarial from titration-based screening of marine natural product extracts KCC Cheng, S Cao, A Raveh, R MacArthur, P Dranchak, G Chlipala, ... Journal of natural products 78 (10), 2411-2422, 2015 | 43 | 2015 |
| Integrating in vitro and in silico approaches to evaluate the “dual functionality” of palmatine chloride in inhibiting and disassembling Tau-derived VQIVYK peptide fibrils E Haj, Y Losev, VG KrishnaKumar, E Pichinuk, H Engel, A Raveh, E Gazit, ... Biochimica et Biophysica Acta (BBA)-General Subjects 1862 (7), 1565-1575, 2018 | 37 | 2018 |
| Novel thiazole and oxazole containing cyclic hexapeptides from a waterbloom of the cyanobacterium Microcystis sp. A Raveh, S Moshe, Z Evron, E Flescher, S Carmeli Tetrahedron 66 (14), 2705-2712, 2010 | 37 | 2010 |
| Aeruginazole A, a Novel Thiazole-Containing Cyclopeptide from the Cyanobacterium Microcystis sp. A Raveh, S Carmeli Organic Letters 12 (15), 3536-3539, 2010 | 33 | 2010 |
| Protease inhibitors from three fishpond water blooms of Microcystis spp. M Lifshits, E Zafrir-Ilan, A Raveh, S Carmeli Tetrahedron 67 (22), 4017-4024, 2011 | 31 | 2011 |
| Identification of protein kinase C activation as a novel mechanism for RGS2 protein upregulation through phenotypic screening of natural product extracts A Raveh, PJ Schultz, L Aschermann, C Carpenter, G Tamayo-Castillo, ... Molecular Pharmacology 86 (4), 406-416, 2014 | 22 | 2014 |
| High‐Throughput Screen of Natural Product Extracts in A Yeast Model of Polyglutamine Proteotoxicity GM Walter, A Raveh, SA Mok, TJ McQuade, CJ Arevang, PJ Schultz, ... Chemical biology & drug design 83 (4), 440-449, 2014 | 21 | 2014 |
| Two novel biological active modified peptides from the cyanobacterium Microcystis sp. A Raveh, S Carmeli Phytochemistry Letters 2 (1), 10-14, 2009 | 20 | 2009 |
| Allosteric inhibitors targeting the calmodulin-PIP2 interface of SK4 K+ channels for atrial fibrillation treatment S Burg, S Shapiro, A Peretz, E Haimov, B Redko, A Yeheskel, L Simhaev, ... Proceedings of the National Academy of Sciences 119 (34), e2202926119, 2022 | 16 | 2022 |
| The combined use of alphavirus replicons and pseudoinfectious particles for the discovery of antivirals derived from natural products PC Delekta, A Raveh, MJ Larsen, PJ Schultz, G Tamayo-Castillo, ... Journal of biomolecular screening 20 (5), 673-680, 2015 | 7 | 2015 |
| Inulin nanostructures: The sweet-spot of carbohydrate self-assembly ZA Arnon, M Grabarics, T Kreiser, A Raveh, K Pagel, E Gazit BioRxiv, 2021.07. 13.451276, 2021 | 4 | 2021 |
| David Gurwitz AK Bansal, JM Benito, S Choi, C Fimognari, J Flores-Murrieta, VG Soto, ... | | 2019 |
| Discovery of alphavirus inhibitors derived from natural products DJM Phillip C. Delekta, Avi Raveh, David H. Sherman Current Topics in Virology 11, 1-17, 2013 | | 2013 |